Pfizer Expands in Emerging Markets, Established Products
This article was originally published in The Pink Sheet Daily
Executive Summary
By licensing in dozens of generics, the company aims to strengthen both its geographic and product diversity.
You may also be interested in...
Another Busy Year of Drug Recalls Led to Shortages of Injectables
Manufacturers recalled more drug products from the U.S. market in 2010 than they had in any year but 2009.
Another Busy Year of Drug Recalls Led to Shortages of Injectables
Manufacturers recalled more drug products from the U.S. market in 2010 than they had in any year but 2009.
Pfizer, Biocon Brush Off Deal Talks As Speculative, But Is There Fire Behind The Smoke?
MUMBAI - Possibilities of a collaborative deal between Pfizer and Biocon have been dismissed as highly speculative by both companies for the last few weeks but going by the latest indications, the two could well be on course to joining forces for a few "significant projects.